Dallas ’ Taysha Gene Therapies – after loading up on more than $100M in funding – files for an IPO
Another North Texas company is looking for a move to the public markets.
Dallas’ Taysha Gene Therapies filed for an initial public offering on Wednesday with the U.S. Securities and Exchange Commission.
The filing follows a haul in July and August of $107.1 million in net proceeds from an additional closing of a Series A convertible preferred stock financing and a Series B convertible preferred stock, according to the document. Since its founding it’s raised more than $125 million.
Taysha…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Brian Womack Source Type: news